White Paper | Supporting The Application Of Computational Pathology In Oncology | September 26, 2023 Share
White Paper | Accelerating Investigation of New Therapies in Earlier Metastatic Treatment Settings | November 18, 2022 Share
White Paper | 2022 Annual Meeting | Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Clinical Trials | November 18, 2022 Share
White Paper | 2022 Annual Meeting | Supporting a Patient-Centric Approach to Dose Optimization in Oncology: The Essential Role of Patient-Reported Outcomes (PROs) | November 18, 2022 Share
White Paper | Circulating Tumor DNA in Development of Therapies for Cancer: An Evidentiary Roadmap to an Early Endpoint for Regulatory Decision-Making | June 29, 2022 Share
White Paper | Beyond Breakthrough: Optimizing the Breakthrough Therapy Designation | April 22, 2022 Share
White Paper | Multi-Cancer Early Detection Screening Tests: Considerations for Use of Real-World Data | March 29, 2022 Share
White Paper | 2021 Annual Meeting | Assessing the Use of ctDNA as an Early Endpoint in Early-Stage Disease | February 3, 2022 Share
White Paper | 2021 Annual Meeting | Optimizing Dosing in Oncology Drug Development | February 3, 2022 Share
